FDC Share Price Today | Stock Price & FDC Share Screener

FDC Pharmaceuticals
Live Share Price NSE
₹331.30
▼ -4.60 (-1.37%)
2026-10-05 00:00:00
Live Share Price BSE
₹331.65
▼ -3.90 (-1.16%)
2026-10-05 00:00:00

As of October 5, 2026, the live FDC share price (NSE: FDC) is ₹331.30 on NSE and ₹331.65 on BSE, down 1.37% from the previous close, with shares trading between ₹328.60 and ₹339.90 in today's trading session, and a 52-week range of ₹321.10–₹460.65. Check FDC yearly price range for the annual price range and momentum. Use the FDC stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today FDC opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹635 and net income of ₹103, with EBITDA of ₹156, an operating margin of 18.0% and a profit margin of 16.2%.

FDC Market Cap ₹5,393.90 Cr.
FDC P/E Ratio (TTM) 18.67
FDC P/B Ratio 2.20
EPS (TTM) ₹17.29
Dividend Yield 1.49%
Debt to Equity 0.01
FDC 52 Week High ₹460.65
FDC 52 Week Low ₹321.10
Operating Margin 18.00%
Profit Margin 16.22%
FDC Revenue (TTM) ₹635.00
EBITDA ₹156.00
Net Income ₹103.00
Total Assets ₹2,919.00
Total Equity ₹2,485.00

FDC Share Price Chart

Track the current stock price of FDC with an interactive chart. Analyse FDC share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete FDC stock quote in one place.

The quote of ₹331.30 sits between the 52-week low of ₹321.10 and the 52-week high of ₹460.65, and the latest session moved -1.37% from the previous close.

FDC Company Profile - Fundamental Screener

Screen FDC company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for FDC shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE258B01022.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E

Identifiers and Leadership

ISIN INE258B01022

FDC Balance Sheet Screener

Screen FDC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹2,919, up from ₹2,714 in 2025.

Latest statistics put total assets at ₹2,919 and shareholder funds at ₹2,485, with a leverage ratio of 0.01.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 2,919 2,714 2,468 2,343 2,270 1,956 1,813 1,640 1,505 1,468
Current Assets 1,133 1,089 1,067 1,025 1,000 934 927 740 722 708
Fixed Assets 999 852 680 699 705 689 674 682 674 678

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 70 71 60 50 42 18 19 16 18 18
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 2,485 2,281 2,097 1,981 1,956 1,734 1,547 1,445 1,276 1,270
Share Capital 16 16 16 17 17 17 17 18 18 18
Reserves & Surplus 2,469 2,265 2,081 1,966 1,940 1,717 1,530 1,428 1,259 1,252

FDC Income Statement Screener - Profit & Revenue Analysis

Screen FDC income statement and profit fundamentals. Analyze FDC quarterly results. FDC reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹635 and net profit was ₹103, equal to earnings per unit of ₹6.35, at an operating margin of 18%.

In that period expenses were ₹478, interest cost ₹2 and tax ₹37. The next period listed, 2026-Jun, shows revenue of ₹715 and net profit of ₹133.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar

Revenue and Expenses

Revenue 635 715 508 684 494 486 482 667 549 483 442 566 514 483 351
Expenses 478 525 438 508 439 433 406 492 444 418 386 414 410 374 322

Operating Costs and Margins

EBITDA 156 191 70 176 54 52 77 175 105 66 56 151 104 109 29
Operating Profit % 18.00% 21.00% 11.00% 22.00% 7.00% 7.00% 12.00% 23.00% 14.00% 10.00% 11.00% 23.00% 16.00% 18.00% 6.00%
Depreciation 14 15 16 15 15 15 10 11 14 13 10 10 10 10 9
Interest 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1

Profit and Earnings

Profit Before Tax 140 175 53 160 38 36 65 163 90 51 45 141 93 98 19
Tax 37 42 15 38 10 8 19 44 18 14 15 31 23 18 9
Net Profit 103 133 39 121 28 28 46 119 72 37 31 110 70 79 10
EPS 6.35 8.14 2.38 7.45 1.75 1.74 2.84 7.31 4.43 2.28 1.85 6.62 4.22 4.86 0.62

FDC Cash Flow Screener - Liquidity Fundamentals

Screen FDC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹200, and net cash flow was an outflow of ₹3.

Over the same period, investing activities used ₹110 and financing activities used ₹93.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 200 318 221 155 162 207 250 112 150 155
Investing Activities -110 -199 -17 11 -145 -77 -98 -121 21 -144

Financing and Net Cash

Financing Activities -93 -92 -202 -180 -10 -129 -142 0 -169 0
Net Cash Flow -3 26 2 -14 7 1 10 -8 1 11

FDC Shareholding Pattern Screener

See FDC shareholding pattern with promoter, FII, and DII holdings. Check FDC promoter holding and ownership changes for FDC on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 69.66%, foreign institutions 2.40%, domestic institutions 6.29% and the public 16.82%, spread across 52,730 shareholders.

The shareholder count was 52,730 in 2026-Mar, compared with 55,045 in 2026-Jun.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun

Promoter Holding

Promoter Holding 69.66% 69.66% 69.66% 69.66% 69.66% 69.66% 69.66% 69.66%

Institutional Investors

FII Holding 2.40% 1.40% 2.55% 2.41% 2.43% 2.32% 2.65% 2.51%
DII Holding 6.29% 6.31% 6.37% 7.17% 6.82% 6.27% 6.94% 6.73%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 16.82% 17.64% 16.22% 16.17% 16.40% 16.97% 16.54% 16.71%
Other Holding 4.83% 4.99% 5.20% 4.59% 4.70% 4.78% 4.22% 4.39%
Shareholder Count 52,730 55,045 53,880 54,445 54,157 53,788 52,377 50,634

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by FDC. FDC dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹5.00 per unit for 2026-March, a yield of 1.49%, compared with ₹5.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹5.00, ₹5.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹5.00 1.49%
2025-March ₹5.00 1.56%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.80 0.28%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹2.25 0.90%

FDC Stock Index Membership - Nifty & Sensex

See which indices include FDC stock. Check FDC index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 9 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX BSE500, BSE INDEX MSL400.

Complete Index List

BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED

FDC Market Events Screener - Corporate Actions

Get FDC corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check FDC stock events that may affect FDC share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 24, 2026, with a record date of September 24, 2026.

It is followed by Quarterly Result Announcement dated August 5, 2026 and Quarterly Result Announcement dated May 27, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-09-24 2026-09-24 Annual General Meeting NA 3.78%
2026-08-05 2026-08-05 Quarterly Result Announcement NA -1.78%
2026-05-27 2026-05-27 Quarterly Result Announcement NA 10.26%
2026-02-11 2026-02-11 Dividend ₹ 5.00 /share 2.66%
2026-02-05 2026-02-05 Quarterly Result Announcement NA 3.96%
2025-11-05 2025-11-05 Quarterly Result Announcement NA 3.59%
2025-09-25 2025-09-25 Annual General Meeting NA 4.36%
2025-08-07 2025-08-07 Quarterly Result Announcement NA -0.64%
2025-05-28 2025-05-28 Quarterly Result Announcement NA -1.68%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -3.50%
2024-11-22 2024-11-22 Dividend ₹ 5.00 /share -10.27%
2024-11-06 2024-11-06 Quarterly Result Announcement NA 4.71%
2024-09-26 2024-09-26 Annual General Meeting NA -0.22%
2023-09-27 2023-09-27 Annual General Meeting NA -0.85%
2023-08-25 2023-08-31 Buyback 500 1.40%

FDC Competitors Screener - Peer Stocks Comparison

Screen FDC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 427,010 35.84 61,674 12.69% 11,565 33.78
Divis Laboratories 244,125 84.36 11,067 13.95% 2,568 49.73
Torrent Pharmaceuticals 181,512 84.01 13,886 20.34% 2,138 41.48
Zydus Life Science 113,616 24.88 27,658 17.64% 5,026 46.18
Cipla 107,890 32.42 29,045 2.24% 3,870 32.87
Laurus Labs 106,517 98.56 6,868 22.01% 890 56.11
Mankind Pharma 102,394 50.48 14,636 14.85% 1,938 55.53
Dr Reddys Laboratories 100,412 31.47 35,059 3.90% 4,158 52.91
Aurobindo Pharma 96,370 25.97 34,145 5.56% 3,503 49.89
Lupin 91,961 16.71 29,039 26.75% 5,356 29.12

FDC Company Announcements - News & Reports Screener

Screen FDC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated September 29, 2026.

The next most recent announcements are dated September 26, 2026 and September 24, 2026.

Date Update Actions
2026-09-29 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-26 Closure of Trading Window -
2026-09-24 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-18 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-17 Typographical Error In The Notice Of 86Th Annual General Meeting. -
2026-09-04 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-03 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-09-01 Business Responsibility and Sustainability Reporting (BRSR) -
2026-09-01 Intimation Of Book Closure And Cut-Off Date In Accordance With Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirement) 2015 -
2026-09-01 Reg. 34 (1) Annual Report. -
2026-09-01 Notice Of 86Th Annual General Meeting For The FY 2025-26 -
2026-09-01 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-27 Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 -
2026-08-13 Grant Of Marketing Authorisation From MHRA UK For Atropine 1.0% W/V Eye Drops Solution. -
2026-08-05 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-08-05 Financial Results For The Quarter Ended June 30 2026 -
2026-08-05 Board Meeting Outcome for Board Meeting Outcome For Outcome For The Board Meeting Held On August 05 2026. -
2026-07-27 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-07-23 Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday August 05 2026. -
2026-06-29 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹331.30, within a 52-week range of ₹321.10 to ₹460.65. The P/E ratio is 18.67 and the P/B ratio is 2.20, with earnings per unit of ₹17.29. Market capitalisation stands at ₹5,393.90 Cr and the dividend yield is 1.49%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.